Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Like many adults over 60, Tom, a patient ... respiratory syncytial virus (RSV) when he tested positive for the common, contagious respiratory virus in the fall of 2022. “I drove my 5-year-old ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

This lack of testing amplifies the misdiagnosis of RSV, as its symptoms are so similar to other, more common respiratory viruses like flu. A lack of recognition can also be seen in older adults ...

Cold, dry air is the ideal climate for viruses like the flu, phenomena and Respiratory Syncytial Virus (RSV), and these low ...

More than one in five older adults hospitalized for respiratory syncytial virus (RSV) infection experienced an acute cardiac event, an observational study found. Among 6,248 hospitalized patients ...

Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study ...

The RSV vaccine leads to better health outcomes among older adults with IBD, including a lower risk for RSV pneumonia.

First discovered in chimpanzees in 1956 and in children the following year, respiratory syncytial virus (RSV) isn’t new ... annual hospitalization of up to 160,000 U.S. adults 60 and older. In recent ...

Arexvy shows 62.9% efficacy against RSV-LRTD over three seasons in adults aged 60 and older. The vaccine demonstrates ... disease and 94.6% efficacy in patients with comorbidities.

vaccination is associated with a lower RSV pneumonia risk and improved health outcomes in patients aged older than 60 years with inflammatory bowel disease (IBD), according to study results ...